meturedepa has been researched along with Leukemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| AMBRUS, JL; RAZIS, DV; ROSS, CA; SOKAL, JE; STUTZMAN, L | 1 |
| PIERUCCI, O; REGELSON, W | 1 |
2 other study(ies) available for meturedepa and Leukemia
| Article | Year |
|---|---|
Clinical experience with a new alkylating agent AB-132, in the treatment of lymphomas and leukemias.
Topics: Alkylating Agents; Antineoplastic Agents; Aziridines; Humans; Leukemia; Lymphoma | 1962 |
THE EFFECT OF RADIATION ON SPLENOMEGALY INDUCED BY THE FRIEND LEUKEMIA VIRUS AND ITS MODIFICATION BY ETHY-N-BIS(2,2-DIMETHYL-ETHYLAMIDINOPHOSPHORO)-CARBAMATE (AB-132), ACTINOMYCIN D, AND AET.
Topics: Alkylating Agents; Amidines; Animals; Antineoplastic Agents; Aziridines; beta-Aminoethyl Isothiourea; Carbamates; Dactinomycin; Friends; Leukemia; Leukemia Virus, Murine; Mice; Oncogenic Viruses; Radiation; Radiation Effects; Radiation-Protective Agents; Research; Splenomegaly | 1964 |